HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Rømer Selected Research

N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamide

8/2010Skin wound healing in MMP2-deficient and MMP2 / plasminogen double-deficient mice.
9/2008Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model.
6/2006Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Rømer Research Topics

Disease

9Neoplasms (Cancer)
08/2015 - 04/2005
8Breast Neoplasms (Breast Cancer)
08/2015 - 02/2005
5Neoplasm Metastasis (Metastasis)
03/2013 - 02/2005
4Wounds and Injuries (Trauma)
09/2010 - 06/2006
2Psoriasis (Pustulosis Palmaris et Plantaris)
05/2014 - 12/2003
2Anthrax
11/2008 - 01/2006
2Carcinogenesis
03/2007 - 07/2005
1Lymphatic Metastasis
08/2015
1Synovitis
04/2014
1Inflammation (Inflammations)
03/2013
1Hyperglycemia
09/2009
1Peritonitis
11/2007
1Intestinal Obstruction (Obstruction, Intestinal)
11/2007
1Anastomotic Leak
11/2007
1Abscess
11/2007
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2002
1Body Weight (Weight, Body)
04/2002

Drug/Important Bio-Agent (IBA)

4Peptide Hydrolases (Proteases)FDA Link
08/2015 - 04/2005
4Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
08/2015 - 02/2005
4PlasminogenIBA
03/2013 - 04/2005
4Metalloproteases (Metalloproteinases)IBA
03/2013 - 03/2006
4FibrinolysinFDA Link
09/2010 - 02/2005
3N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA
08/2010 - 06/2006
3Matrix Metalloproteinases (MMPs)IBA
07/2009 - 06/2006
2interleukin 20 (IL-20)IBA
05/2014 - 12/2003
2Tissue Plasminogen Activator (Alteplase)FDA Link
09/2010 - 11/2008
2Monoclonal AntibodiesIBA
09/2010 - 06/2007
2FibrinIBA
09/2010 - 08/2008
2Plasminogen Activators (Plasminogen Activator)IBA
09/2010 - 01/2006
2Insulin (Novolin)FDA Link
09/2009 - 06/2002
2Messenger RNA (mRNA)IBA
07/2009 - 07/2005
2Matrix Metalloproteinase InhibitorsIBA
09/2008 - 06/2006
1Urokinase Plasminogen Activator ReceptorsIBA
08/2015
1von Willebrand FactorIBA
04/2014
1CollagenIBA
09/2008
1AntibodiesIBA
06/2007
1Tryptophan (L-Tryptophan)FDA Link
06/2006
1Plasma KallikreinIBA
06/2006
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
06/2006
1RNA (Ribonucleic Acid)IBA
03/2006
1DisintegrinsIBA
03/2006
1ThrombospondinsIBA
03/2006
1ProdrugsIBA
01/2006
1AntigensIBA
07/2005
1Protease Inhibitors (Protease Inhibitor)IBA
04/2005
1Therapeutic UsesIBA
04/2005
1Cocaine (Cocaine HCl)IBA
04/2002
1NeuropeptidesIBA
04/2002
1Amphetamine (Amfetamine)FDA LinkGeneric
04/2002
1Proglucagon (Glucagon Precursors)IBA
04/2002
1Peptides (Polypeptides)IBA
04/2002

Therapy/Procedure

5Therapeutics
06/2007 - 02/2005
1General Anesthesia
11/2007
1Lasers (Laser)
07/2005
1Drug Therapy (Chemotherapy)
04/2002